MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.

ALIM Alimera Sciences Forecast, Technical & Fundamental Analysis

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the U... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL343.461.46
+0.43%
Apple
BTC.X81500.805000-640.656250
-0.78%
Bitcoin cryptocurrency
SPY763.25-8.54
-1.11%
State Street SPDR S&P 500 ETF (SPY)
TSLA354.72-7.72
-2.13%
Tesla
GME26.81-1.21
-4.32%
GameStop Corp
Related Blogs
NXGL

JBDI vs NXGL: Contrasting Micro-Cap Narratives in AI Speculation and Healthcare Transition

NXGL

HUBC vs NXGL: Contrasting Small-Cap Stories in Cybersecurity and Healthcare

NXGL

Comparing NXGL and WFF: Two Small-Cap Nasdaq Names with Divergent Paths

ANGO

AngioDynamics (ANGO) Drops -24.8% Over 30 Days: Earnings Reaction and Outlook

NXGL

NWGL and NXGL: Contrasting Two Micro-Cap Stories in Forestry and Healthcare

View all blogs related to
#PharmaceuticalsOther
Interesting Articles

How fast should my portfolio grow?

Top Silver Mining Companies for Investment

Best Communication Stocks To Watch in 2024

What Is Sector Rotation?

Wall Street's Top Investment Firms

View all articles
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry PharmaceuticalsOther

Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com
Alimera Sciences (ALIM) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com